Shin Nippon Biomedical Laboratories (FRA:YB3) Beginning Cash Position : €0.0 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Beginning Cash Position?

Shin Nippon Biomedical Laboratories's Beginning Cash Position for the quarter that ended in Dec. 2023 was €0.0 Mil.

Shin Nippon Biomedical Laboratories's annual Beginning Cash Position declined from Mar. 2022 (€55.7 Mil) to Mar. 2023 (€31.8 Mil) but then increased from Mar. 2023 (€31.8 Mil) to Mar. 2024 (€56.5 Mil).

Shin Nippon Biomedical Laboratories Beginning Cash Position Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories Beginning Cash Position Chart

Shin Nippon Biomedical Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Beginning Cash Position

Get a 7-Day Free Trial

43.16

40.52

55.74

31.77

56.48

Shin Nippon Biomedical Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Shin Nippon Biomedical Laboratories Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Shin Nippon Biomedical Laboratories Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Shin Nippon Biomedical Laboratories (FRA:YB3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (FRA:YB3) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

2395:Japan

Address

8-1 Akashi-cho, Tokyo, JPN

Website

http://www.snbl.co.jp

Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (FRA:YB3) Headlines

No Headlines